Back to
KLP KAPITALFORVALTNING AS
FDMT2 quarters
Position history for
KLP KAPITALFORVALTNING AS's holdings in 4D MOLECULAR THERAPEUTICS IN
KLP KAPITALFORVALTNING AS previously held 0 shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $0 as of 2025-Q1.
Final Value
$0
Final Shares
0
Total Value Change
-$47,902
Total Shares Change
-8,600
Quarter-by-Quarter History
Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.